HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- ((4- (2- cyanophenyl)- 1- piperazinyl)methyl)- 3- methylbenzamide

a D4 dopamine receptor agonist
Also Known As:
N-(4-2-cyanophenylpiperazin-1-ylmethyl)-3-methylbenzamide maleate; PD 168,077; PD 168077; PD-168,077; PD-168077; PD168,077; PD168077
Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Liu, Xue-Song: 1 article (01/2020)
2. Qi, Chun-Lei: 1 article (01/2020)
3. Wang, Da-Xin: 1 article (01/2020)
4. Wu, Geng-Ze: 1 article (01/2020)
5. Xiong, Ting: 1 article (01/2020)
6. Yang, Yu-Xue: 1 article (01/2020)
7. Zeng, Chun-Yu: 1 article (01/2020)
8. Zeng, Jing: 1 article (01/2020)
9. Cole, Susan: 1 article (06/2011)
10. Grayson, Ben: 1 article (06/2011)

Related Diseases

1. Infarction (Infarctions)
2. Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
3. Cognitive Dysfunction
4. Schizophrenia (Dementia Praecox)

Related Drugs and Biologics

1. Troponin T (Troponin T1)
2. Trinitrotoluene (TNT)
3. L-Lactate Dehydrogenase (Lactate Dehydrogenase)
4. Dopamine D4 Receptors (Dopamine D4 Receptor)
5. 2-(3',4',5',6'-tetrahydro-2'H-(2,4') bipyridinyl-1'-yl)-N-m-tolyl-acetamide